期刊文献+

慢性粒-单核细胞白血病——附16例分析 被引量:10

Chronicmyelomonocyticleukemia:ananalysisof16cases
原文传递
导出
摘要 为重新全面认识慢性粒-单核细胞白血病(CMML)特征。对16例CMML患者的临床和实验室资料进行分析。结果:CMML患者起病症状多为非特异性,外周血可出现少量原幼粒、单核细胞,成熟单核细胞比例均>0.10,骨髓原始、早幼粒细胞多>0.05,原幼单核细胞>0.05,成熟单核细胞>0.20,伴有明显的二或三系病态造血。表达额外的ADA2同工酶。化疗耐受性差。外周血白细胞数和单核细胞数明显升高(分别>50×109/L和10×109/L),骨髓原始及早幼粒细胞与原幼单核细胞>0.30者预后很差。结果表明:CMML是一组异质性疾病,建议将CMML单独列为一组疾病,从MDS中分出来,并将CMML分为慢性期、加速期和急变期。 Tocharacterizethechronicmyelomonocyticleukemia(CMML),theclinicalandlaborato-rydataof16CMMLpatientswereanalyzed.Therewereafewmyeloblasts,immaturegranulocytes,monoblastsandpromonocytesandmorethan0.10ofmonocytesintheperipheralblood;andmorethan0.05ofmyeloblastsandpromyelocytes,andmorethan0.20ofmonocytesinthebonemarrow(BM).Alpatientshadbi-ortrilineagedyshematopoieses.TheredbloodcelsofaltheexaminedpatientsexpressedextraADA2isozyme.TheprognosiswasverypoorforthepatientswithWBC>50×109/L,monocytes>10×109/L,andthetotalamountofmyeloblasts,promyelocytes,monoblastsandpromonocytesinBMmorethan0.30.TheresultssuggestthatCMMLisaheterogeneousdisorderwhichshouldbeseperatedfromMDS.TheclinicalcoursesofCMMLcanbesubdividedintothreestages:chronicphase,acceleratedphaseandblastcrisis.
出处 《中华血液学杂志》 CAS CSCD 北大核心 1996年第12期626-628,共3页 Chinese Journal of Hematology
关键词 慢性 白血病 粒单核细胞性 病理学 诊断 Leukemia,myelomonocytic,chronicMyelodysplasticsyndromes
  • 相关文献

参考文献1

  • 1郑天林,中华内科杂志,1990年,39卷,342页

同被引文献58

  • 1李达,吴顺杰,江志生,康颖,崔徐江,陈琪,梁冰,吴秉毅.中药序贯介入造血干细胞移植治疗血液病2例[J].中医杂志,2006,47(3):208-209. 被引量:8
  • 2刘元波,郝玉书,卞寿庚,钱林生.慢性粒-单核细胞白血病临床及血液学特征鉴定——附35例分析[J].中华血液学杂志,1996,17(12):629-633. 被引量:9
  • 3管俊,姜扬文.慢性粒-单核细胞白血病三例并文献复习[J].白血病.淋巴瘤,2007,16(1):63-65. 被引量:1
  • 4CHESON B D, GREENBERG P L, BENNETT J M, et al. Clinical application and proposal for modification of the International Working Group (IWG)response criteria in myelodysplasia[Jj. Blood,2006,108:419 - 425.
  • 5VALENT P, HORNY H P, BENNETT J M, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes:Consensus statements and report from a working conference [J]. Leuk Res, 2007,31:727 - 736.
  • 6KROGER N,ZABELINA T, GARDIOLAP, et al. Allog enetic stem cell transplantion for adult chronic myelomonocytic lenkemia:a report on behalf of the Chronic Leukemia Working Party the European Group for Blood and Marrow Transplantation(EBMT) [J]. Br J Haematol, 2002,118(1):67 -73.
  • 7Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 2005,365 : 1054-1061.
  • 8Cannella L, Breccia M, Latagliata R, et al. Clinical and prognostic features of patients with myelodysplastic/ myeloproliferative syndrome categorized as unclassified (MDS/ MPD-U) by WHO classification. Leuk Res, 2008,32:514-516.
  • 9ORAZI A,GERMING U.The myelodysplastic/myeloproliferative neoplasms:myeloproliferative diseases with dysplastic features[J].Leukemia,2008,22:1308-1319.
  • 10LACRONIQUE-GAZAILLE C,CHAURY M P,LE G A,et al.A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes:expression of CD56 in CMML[J].Haematologica,2007,92:859-860.

引证文献10

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部